[Report] Urgent Forum on Drug Pricing Reform (December 13, 2016)
date : 12/13/2016
There has been a lot of action on drug pricing recently, centered on Government activities. On November 25, 2016, Prime Minister Shinzo Abe instructed the Council on Economic and Fiscal Policy and the Ministry of Health, Labour and Welfare to draw up an outline for a comprehensive revision of Japan’s prescription drug pricing system by the end of the year. At a post-cabinet meeting press conference on November 29, Minister of Health, Labour and Welfare Yasuhisa Shiozaki unveiled a plan to review the prices of in-demand drugs up to four times a year. In the latest meeting by the Council on Economic and Fiscal Policy on December 7, its members agreed on a plan to review drug pricing at least once a year.
In response to this forthcoming reform in health policy, we have decided to convene the Urgent Session on Drug Pricing Reform with domestic stakeholders on December 9, 2016. This urgent forum was held with the aim of producing ideas toward achievable solutions through fair and global multi-stakeholder discussion related to issues of not only on drug pricing, but also initiatives to streamline medical care through technological innovation and the design of systems to ensure the sustainability of social security.
Many recommendations and comments were made by the private, public, and academic panel discussion members, as well as the other participants that attended the forum. HGPI has compiled and prioritized points that need to be discussed based on these recommendations and comments. The report can be downloaded from the right column of this page.
*English version has been uploaded (December 20, 2016).
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)